AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18212687
Drug: Sole intramuscular
RxNorm normalized name: English sole
DrugBank: English sole (DB10904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sole intramuscular (IM) administration of autologous bone marrow mononuclear cells (BMC)
Trial: 18212687
Drug: Combined IA+IM
RxNorm normalized name: magnesium aluminum silicate type Ia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined IA+IM administration of autologous BMC
Trial: 12454805
Drug: Nurse-led cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led cognitive-behavioral treatment (CBT) pain management program
Trial: 10322244
Drug: Cimetidine 1600
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 1600 mg
Trial: 28984096
Drug: Ketamine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (1 mg/kg IV and 0.5 mg/kg/h)
Trial: 25349864
Drug: Inhalation technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation technique with spacer
Trial: 25349864
Drug: Inhalation technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation technique without spacer
Trial: 23565943
Drug: Monosodium glutamate
RxNorm normalized name: Monosodium Glutamate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monosodium glutamate (MSG) intake (150 mg/kg)
Trial: 23565943
Drug: Placebo (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (24 mg/kg NaCl)
Trial: 16403616
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with standardized mite extracts (D.p. and D.f.)
Trial: 8694295
Drug: 4.0 mg
RxNorm normalized name: LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.0 mg of intrathecal morphine (Group MS)
Trial: 1286050
Drug: EEP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EEP chemotherapy (Etoposide + Epirubicin + Cisplatin)
Trial: 1286050
Drug: FEM chemotherapy
RxNorm normalized name: Fem Choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEM chemotherapy (Control)
Trial: 1286050
Drug: EEP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EEP chemotherapy
Trial: 3890307
Drug: CAP combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAP combination chemotherapy
Trial: 3890307
Drug: CMFVP combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMFVP combination chemotherapy
Trial: 3890307
Drug: CAP combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAP combination chemotherapy (as second-line treatment)
Trial: 31145885
Drug: Early insertion
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early insertion of ENG implant
Trial: 31145885
Drug: Delayed insertion
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed insertion of ENG implant
Trial: 30307302
Drug: Dairy products
RxNorm normalized name: Food - Dairy Products, Whey, Cow's Milk
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy products enriched with calcium and vitamin D (250 ml daily)
Trial: 1481657
Drug: Topical nasal
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nasal decongestant in different formulations (varied viscosities)
Trial: 18207532
Drug: Preoperative only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative only protocol (single dose of cefazolin IV)
Trial: 18207532
Drug: Preoperative with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative with extended postoperative antibiotic protocol (single dose of cefazolin IV followed by cefazolin IV every 8 hours for 3 days and oral cephalexin every 6 hours for 7 days)
Trial: 8877348
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily for up to three months
Trial: 31672146
Drug: liraglutide 3
RxNorm normalized name: liraglutide 3.6 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide 3 mg
Trial: 29680881
Drug: Baricitinib 4
RxNorm normalized name: baricitinib 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baricitinib 4 mg daily
Trial: 27028914
Drug: Baricitinib 2
RxNorm normalized name: baricitinib 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baricitinib 2 mg daily
Trial: 12399209
Drug: Meningococcal A/C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal A/C plain polysaccharide vaccine (Mps)
Trial: 12399209
Drug: Meningococcal A/C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal A/C polysaccharide-diphtheria toxoid conjugate vaccine (Mcj)
Trial: 7838584
Drug: Morphine (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.075 mg/kg)
Trial: 3202206
Drug: Metoprolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (0.15 mg/kg)
Trial: 11485845
Drug: Topical delta-aminolaevulinic
RxNorm normalized name: Delta Tritex Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical delta-aminolaevulinic acid (ALA) applied under an occlusive dressing for 5 hours on 64 warts.
Trial: 30333337
Drug: Chloride liberal
RxNorm normalized name: CHLORIDE
DrugBank: Chloride ion (DB14547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloride liberal intravenous fluids (IVFs) including hydroxyethyl starch (130/0.4) in 0.9% normal saline (Voluven), 0.9% normal saline, and Ringer's lactate
Trial: 30333337
Drug: Chloride restricted
RxNorm normalized name: CHLORIDE
DrugBank: Chloride ion (DB14547)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloride restricted intravenous fluids (IVFs) including hydroxyethyl starch (130/0.4) in balanced colloid solution (Volulyte) and balanced salt crystalloid solution (PlasmaLyte A)
Trial: 20148732
Drug: Endoscopic flushes
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic flushes of 20-ml aliquots of water containing Gascon, with or without Pronase
Trial: 20148732
Drug: Endoscopic flushes
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic flushes of 20-ml aliquots of water
Trial: 11666127
Drug: TTFCA (total
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA (total triterpenic fraction of Centella asiatica) at a dose of 60 mg thrice daily for 12 months
Trial: 9699198
Drug: Tibolone, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone, 2.5 mg/day
Trial: 9699198
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (CEE), 0.625 mg/day plus medroxyprogesterone acetate (MPA), 5 mg/day
Trial: 7989632
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate syrup (30 mg/Kg) and diazepam solution (0.2 mg/Kg)
Trial: 7989632
Drug: Chloral hydrate
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloral hydrate syrup (30 mg/Kg) and diphenhydramine HCl (1.5 mg/Kg)
Trial: 4537850
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution as the sole intravenous fluid
Trial: 4537850
Drug: Three different
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three different intravenous solutions to meet all fluid and electrolyte requirements
Trial: 31067371
Drug: Progesterone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (400 mg vaginal suppositories twice daily)
Trial: 31067371
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching vaginal suppositories)
Trial: 23662176
Drug: Inhaled epoprostenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled epoprostenol (iPGI2) at 50 ng/kg/min
Trial: 23662176
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) in HFpEF patients
Trial: 23662176
Drug: Inhaled epoprostenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled epoprostenol (iPGI2) in HFpEF patients
Trial: 23662176
Drug: Inhaled epoprostenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled epoprostenol (iPGI2)
Trial: 23662176
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of iNO and iPGI2
Trial: 21496284
Drug: Anthracycline-containing chemotherapy
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline-containing chemotherapy (FE(100)C)
Trial: 21496284
Drug: Biological risk
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological risk assessment using uPA/PAI-1
Trial: 11104313
Drug: Psychosocial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatment alone
Trial: 11104313
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Medication + Psychosocial treatment)
Trial: 9195505
Drug: CAMPATH-1H (C1H)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAMPATH-1H (C1H) 0.5 mg subcutaneously twice per week
Trial: 9195505
Drug: CAMPATH-1H (C1H)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAMPATH-1H (C1H) 1.0 mg subcutaneously twice per week
Trial: 30371745
Drug: Proposed cumulative
RxNorm normalized name: Propoven
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proposed cumulative incidence regression models for dynamic treatment regimens (DTRs)
Trial: 26709136
Drug: G‐CSF and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF and Sitagliptin (GS)
Trial: 15811208
Drug: Daily ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily ibandronate (2.5 mg)
Trial: 15811208
Drug: Intermittent ibandronate
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent ibandronate (20 mg every other day for 12 doses every 3 months)
Trial: 2252195
Drug: Background infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Background infusion of ketamine, midazolam, and alfentanil with inhalation of isoflurane in oxygen-enriched air
Trial: 6997513
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard surgical therapy)
Trial: 19835754
Drug: Delayed implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed implant placement with socket grafting followed by provisionalization after 4 months
Trial: 17360317
Drug: Controlling for
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlling for age, gender, maximum grade of acute GVHD, and treatment arm
Trial: 3311138
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for IGT
Trial: 2619026
Drug: Benzydamine hydrochloride
RxNorm normalized name: benzydamine hydrochloride
DrugBank: Benzydamine (DB09084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzydamine hydrochloride (Difflam) spray
Trial: 25214516
Drug: No study
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No study treatment (Control)
Trial: 23392966
Drug: Apatite-coated magnetite
RxNorm normalized name: magnesite
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatite-coated magnetite nanoparticles, injected intravenously or intraperitoneally at doses ranging from 100 to 2,500 mg/Kg.
Trial: 19280324
Drug: CRA13 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRA13 administered in fed state
Trial: 19280324
Drug: CRA13 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRA13 administered in fasted state
Trial: 15636272
Drug: Triazolam (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (one weight-based dose administered 60 minutes prior to treatment)
Trial: 15636272
Drug: Triazolam with
RxNorm normalized name: Triazolam
DrugBank: Triazolam (DB00897)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triazolam with supplemental dosage (half the initial dose)
Trial: 8501567
Drug: High-titer Edmonston-Zagreb
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-titer Edmonston-Zagreb (EZ) measles vaccine
Trial: 8501567
Drug: Inactivated poliomyelitis
RxNorm normalized name: Inactivated poliomyelitis vaccine (V.C.O.) type 2 MEF1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated poliomyelitis vaccine and standard Schwarz vaccine
Trial: 30202998
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CoQ10) alone or in combination with vitamin E
Trial: 30202998
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CoQ10 and Vitamin E
Trial: 28566022
Drug: Recovery-Oriented Cognitive
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery-Oriented Cognitive Therapy (CT-R)
Trial: 23438670
Drug: Gefitinib 500mg
DrugBank: Gefitinib (DB00317)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gefitinib 500mg oral daily until progression or severe toxicity
Trial: 18469236
Drug: 250 mg/d
RxNorm normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/d EPA + DHA esterified to phospholipid (PL-n-3) (300 mg/d phosphatidylserine)
Trial: 10337210
Drug: French cassoulet
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: French cassoulet (CASS) 22.5 g/kg
Trial: 10337210
Drug: International sauerkraut
FDA approved: no
EMA approved: no
PMDA approved: no
Description: International sauerkraut (CHOU) 22.5 g/kg
Trial: 1770067
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity maintained (G)
Trial: 7104136
Drug: Inhalation anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anaesthesia with enflurane
Trial: 25164450
Drug: Glucose group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose group (acetated Ringer solution with 1.5% glucose)
Trial: 25164450
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (acetated Ringer solution without glucose)
Trial: 16279144
Drug: Treatment effects
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment effects estimated within each trial assuming a common treatment effect across trials.
Trial: 16279144
Drug: Subgrouping patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgrouping patients to investigate covariate-treatment interactions.
Trial: 9788003
Drug: Disulfiram 500
RxNorm normalized name: disulfiram 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disulfiram 500 mg/day
Trial: 9788003
Drug: Cocaine 1
RxNorm normalized name: cocaine 135 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine 1 mg/kg
Trial: 9788003
Drug: Cocaine 2
RxNorm normalized name: cocaine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine 2 mg/kg
Trial: 9788003
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for cocaine administration
Trial: 2198928
Drug: Cyclosporin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (10 mg/kg/day)
Trial: 832447
Drug: Tetrahydrocannabinol (THC)
RxNorm normalized name: tetrahydrocannabinol (THC)
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydrocannabinol (THC) 0.022 mg/kg
Trial: 832447
Drug: Tetrahydrocannabinol (THC)
RxNorm normalized name: tetrahydrocannabinol (THC)
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetrahydrocannabinol (THC) 0.044 mg/kg
Trial: 832447
Drug: Diazepam 0.157
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.157 mg/kg
Trial: 27712113
Drug: Palonosetron IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron IV (0.75 mg)
Trial: 27712113
Drug: Palonosetron IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron IV (0.75 mg) and hydroxyzine PO (100 mg)
Trial: 26027624
Drug: Tai Chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi Chuan (TCC) cardiac rehabilitation program, 3 weekly sessions for 12 weeks.
Trial: 26027624
Drug: Full-body stretching
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-body stretching exercises (control group), 3 weekly sessions for 12 weeks.
Trial: 15301901
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium administration
Trial: 15301901
Drug: Magnesium administration
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium administration to replenish low serum magnesium concentrations
Trial: 15301901
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate for treatment of torsade de pointes
Trial: 11702324
Drug: Hydromorphone 283
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone 283 micrograms (low dose, LD)
Trial: 11702324
Drug: Hydromorphone 566
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone 566 micrograms (high dose, HD)
Trial: 11702324
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hydromorphone 283 micrograms and metamizole 50 mg (low dose hydromorphone + metamizole, LM)
Trial: 2218190
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of therapies with independent activity
Trial: 2218190
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of therapy to patients in a disease-free (remission) state
Trial: 75392
Drug: Flufenamic acid
RxNorm normalized name: Flufenamic acid
DrugBank: Flufenamic acid (DB02266)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flufenamic acid (200 mg three times a day)
Trial: 10379482
Drug: Interferon-alfa (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alfa (6 MU t.i.w.) plus ribavirin (1000 mg/daily)
Trial: 7675230
Drug: Tegretol-XR 200-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegretol-XR 200-mg tablets every 12 hours
Trial: 7675230
Drug: Tegretol 200-mg
RxNorm normalized name: carbamazepine 200 MG [Tegretol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegretol 200-mg tablets three or four times daily
Trial: 7222869
Drug: Intracervically applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracervically applied Prostaglandin F2 alpha Gel
Trial: 30730438
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy in patients with intracranial pressure monitoring
Trial: 27334444
Drug: Control condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control condition (treatment as usual + online psychoeducation about depression)
Trial: 17823418
Drug: Twice-weekly strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly strength training for 2 years
Trial: 8173852
Drug: 24 h
RxNorm normalized name: Immune 24 Hour +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 h bed rest following intra-articular steroid injection
Trial: 8173852
Drug: Routine outpatient
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine outpatient injections (no rest)
Trial: 24018781
Drug: Olmesartan/amlodipine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/amlodipine combination 20/5 mg
Trial: 20957980
Drug: Ipilimumab (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipilimumab (0.3, 3, or 10 mg/kg)
Trial: 20957980
Drug: Ipilimumab (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipilimumab (all doses)
Trial: 1556836
Drug: Intravesical instillation
RxNorm normalized name: ADSTILADRIN Suspension for Intravesical Instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical instillation of BCG Tokyo 172 strain (80 mg in 40 ml saline, once a week for 8 weeks)